Comparative Performance of HALP, PNI, and CONUT Scores in No-Reflow Among Patients with Acute Coronary Syndrome: A

Mert Deniz Savcilioglu1, Nil Savcilioglu1, Nezihe Otay Lule2

  • 1Cardiology Department, Faculty of Medicine, Gaziantep University, 27310 Gaziantep, Turkey.

Insights

The Controlling Nutritional Status (CONUT) score demonstrated the greatest improvement in predicting no-reflow after acute coronary syndrome (ACS) interventions. While CONUT showed promise, further multicenter studies are needed to confirm its superiority over HALP and PNI scores.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Biomarkers

Background:

  • Nutritional impairment is linked to poor outcomes in acute coronary syndrome (ACS).
  • The predictive value of nutritional scores for the no-reflow phenomenon in ACS patients is not fully understood.
  • This study compares Hemoglobin-Albumin-Lymphocyte-Platelet (HALP), Prognostic Nutritional Index (PNI), and Controlling Nutritional Status (CONUT) scores for no-reflow assessment.

Purpose of the Study:

  • To evaluate and compare the efficacy of HALP, PNI, and CONUT scores in assessing the no-reflow phenomenon in ACS patients undergoing percutaneous coronary intervention (PCI).
  • To determine which nutritional index offers the best predictive performance for no-reflow post-PCI.

Main Methods:

  • Prospective study of 279 consecutive ACS patients undergoing PCI.
  • Calculation of HALP, PNI, and CONUT scores using admission laboratory data.
  • No-reflow defined as TIMI flow grade ≤ 2 post-PCI; statistical analyses included logistic regression, ROC analysis, NRI, IDI, and decision curve analysis.

Main Results:

  • No-reflow occurred in 16.5% of patients.
  • All three nutritional indices (HALP, PNI, CONUT) were significantly associated with no-reflow.
  • CONUT score independently predicted no-reflow (OR 1.728, p=0.002) and showed the largest improvement in model discrimination (AUC 0.770), NRI (0.757), and IDI (0.104) compared to clinical models alone, though not statistically superior to HALP or PNI in pairwise comparisons.

Conclusions:

  • The CONUT score demonstrated the most significant incremental improvement in predicting no-reflow among the evaluated nutritional indices in ACS patients.
  • While CONUT showed the greatest potential, statistically significant superiority over HALP and PNI was not established.
  • Findings are exploratory and require validation in larger, multicenter studies to confirm the clinical utility of CONUT for no-reflow assessment in ACS.